Form 4: Expensify Director Sells 9,000 Shares Under 10b5-1 Plan

Expensify Director Daniel Vidal sold 9,000 shares of Class A Common Stock for a weighted average price of $1.60 per share on November 3, 2025, under a pre-arranged trading plan.

Summary

• Daniel Vidal, a Director at Expensify, Inc. (EXFY), reported a sale of 9,000 shares of Class A Common Stock.
• The transaction occurred on November 3, 2025.
• The shares were sold at a weighted average price of $1.60 per share, with individual transactions ranging from $1.59 to $1.63.
• This sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Vidal on December 27, 2024.
• Following this transaction, Daniel Vidal beneficially owns 317,857 shares of Class A Common Stock directly.

Sentiment

Score: 3

Explanation: A director's sale of shares, even under a 10b5-1 plan, can be perceived as a negative signal regarding future company performance or valuation, leading to a slightly negative sentiment.

Negatives

• A director's sale of shares, even under a pre-arranged plan, can be perceived by the market as a signal of reduced confidence in the company's near-term prospects or valuation.

Future Outlook

This filing, a Form 4, does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction report does not provide specific industry context or relate to broader industry trends beyond the individual company's stock activity.

Stakeholder Impact

• Shareholders may view the director's sale as a potential indicator of reduced confidence, which could influence their investment decisions.

Key Dates

Recommendation

The sale of shares by a director, even under a pre-arranged 10b5-1 plan, can signal a lack of conviction or a desire for diversification. While not an immediate 'sell' trigger without further context on the director's overall holdings or company fundamentals, it warrants a 'hold' recommendation to observe further developments and management sentiment.

Keywords

Expensify, EXFY, insider trading, Form 4, stock sale, director, Daniel Vidal, 10b5-1 plan